BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18165406)

  • 1. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.
    Arbyn M; Bergeron C; Klinkhamer P; Martin-Hirsch P; Siebers AG; Bulten J
    Obstet Gynecol; 2008 Jan; 111(1):167-77. PubMed ID: 18165406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid AI-assistive diagnostic model permits rapid TBS classification of cervical liquid-based thin-layer cell smears.
    Zhu X; Li X; Ong K; Zhang W; Li W; Li L; Young D; Su Y; Shang B; Peng L; Xiong W; Liu Y; Liao W; Xu J; Wang F; Liao Q; Li S; Liao M; Li Y; Rao L; Lin J; Shi J; You Z; Zhong W; Liang X; Han H; Zhang Y; Tang N; Hu A; Gao H; Cheng Z; Liang L; Yu W; Ding Y
    Nat Commun; 2021 Jun; 12(1):3541. PubMed ID: 34112790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid-based cytology: evaluation of effectiveness, cost-effectiveness, and application to present practice.
    Cox JT
    J Natl Compr Canc Netw; 2004 Nov; 2(6):597-611. PubMed ID: 19780303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
    Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial.
    Siebers AG; Klinkhamer PJ; Grefte JM; Massuger LF; Vedder JE; Beijers-Broos A; Bulten J; Arbyn M
    JAMA; 2009 Oct; 302(16):1757-64. PubMed ID: 19861667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of effectiveness of Pap smear versus visual inspection with acetic acid and visual inspection with Lugol's iodine for mass screening of premalignant and malignant lesion of cervix.
    Consul S; Agrawal A; Sharma H; Bansal A; Gutch M; Jain N
    Indian J Med Paediatr Oncol; 2012 Jul; 33(3):161-5. PubMed ID: 23248422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid-based cytology versus conventional cytology for evaluation of cervical Pap smears: experience from the first 1000 split samples.
    Singh VB; Gupta N; Nijhawan R; Srinivasan R; Suri V; Rajwanshi A
    Indian J Pathol Microbiol; 2015; 58(1):17-21. PubMed ID: 25673585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
    Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is a liquid-based cytology more sensitive than a conventional Pap smear?
    Sigurdsson K
    Cytopathology; 2013 Aug; 24(4):254-63. PubMed ID: 23331613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Screening: Should Cancer Screening be Essential Component of Primary Health Care in Developing Countries?
    Bobdey S; Balasubramanium G; Kumar A; Jain A
    Int J Prev Med; 2015; 6():56. PubMed ID: 26236443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery.
    Gyamfi-Bannerman C; Thom EA; Blackwell SC; Tita AT; Reddy UM; Saade GR; Rouse DJ; McKenna DS; Clark EA; Thorp JM; Chien EK; Peaceman AM; Gibbs RS; Swamy GK; Norton ME; Casey BM; Caritis SN; Tolosa JE; Sorokin Y; VanDorsten JP; Jain L;
    N Engl J Med; 2016 Apr; 374(14):1311-20. PubMed ID: 26842679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus vaccine and systemic lupus erythematosus.
    Gatto M; Agmon-Levin N; Soriano A; Manna R; Maoz-Segal R; Kivity S; Doria A; Shoenfeld Y
    Clin Rheumatol; 2013 Sep; 32(9):1301-7. PubMed ID: 23624585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.
    Ronco G; Dillner J; Elfström KM; Tunesi S; Snijders PJ; Arbyn M; Kitchener H; Segnan N; Gilham C; Giorgi-Rossi P; Berkhof J; Peto J; Meijer CJ;
    Lancet; 2014 Feb; 383(9916):524-32. PubMed ID: 24192252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health consequences of prophylactic exposure to antenatal corticosteroids among children born late preterm or term.
    Eriksson L; Haglund B; Ewald U; Odlind V; Kieler H
    Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1415-21. PubMed ID: 23006062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial.
    Ronco G; Giorgi-Rossi P; Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Ghiringhello B; Girlando S; Gillio-Tos A; De Marco L; Naldoni C; Pierotti P; Rizzolo R; Schincaglia P; Zorzi M; Zappa M; Segnan N; Cuzick J;
    Lancet Oncol; 2010 Mar; 11(3):249-57. PubMed ID: 20089449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
    Lehtinen M; Paavonen J; Wheeler CM; Jaisamrarn U; Garland SM; Castellsagué X; Skinner SR; Apter D; Naud P; Salmerón J; Chow SN; Kitchener H; Teixeira JC; Hedrick J; Limson G; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; De Carvalho NS; Germar MJ; Peters K; Mindel A; De Sutter P; Bosch FX; David MP; Descamps D; Struyf F; Dubin G;
    Lancet Oncol; 2012 Jan; 13(1):89-99. PubMed ID: 22075171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.
    Katki HA; Kinney WK; Fetterman B; Lorey T; Poitras NE; Cheung L; Demuth F; Schiffman M; Wacholder S; Castle PE
    Lancet Oncol; 2011 Jul; 12(7):663-72. PubMed ID: 21684207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.